Assuntos: TOMOGRAFIA DE COERÊNCIA ÓPTICA, FÁRMACOS, TERAPIA A LASER, DIABETES MELLITUS (COMPLICAÇÕES)
ABNT
FERRAZ, Daniel A. et al. A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non–high-risk proliferative diabetic retinopathy. Retina, v. 35, p. 280-287, 2015Tradução . . Disponível em: https://doi.org/10.1097/IAE.0000000000000363. Acesso em: 18 out. 2024.APA
Ferraz, D. A., Vasquez, L. M., Preti, R. C., Motta, A., Sophie, R., Bittencourt, M. G., et al. (2015). A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non–high-risk proliferative diabetic retinopathy. Retina, 35, 280-287. doi:10.1097/IAE.0000000000000363NLM
Ferraz DA, Vasquez LM, Preti RC, Motta A, Sophie R, Bittencourt MG, Sepah YJ, Monteiro MLR, Nguyen QD, Takahashi WY. A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non–high-risk proliferative diabetic retinopathy [Internet]. Retina. 2015 ; 35 280-287.[citado 2024 out. 18 ] Available from: https://doi.org/10.1097/IAE.0000000000000363Vancouver
Ferraz DA, Vasquez LM, Preti RC, Motta A, Sophie R, Bittencourt MG, Sepah YJ, Monteiro MLR, Nguyen QD, Takahashi WY. A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non–high-risk proliferative diabetic retinopathy [Internet]. Retina. 2015 ; 35 280-287.[citado 2024 out. 18 ] Available from: https://doi.org/10.1097/IAE.0000000000000363